Peter Dolan is the Chair of ChildObesity180. He has served as Chairman and CEO of Bristol-Myers Squibb and later as Chairman and CEO of Gemin X, a venture capital backed oncology company that was successfully sold to Cephalon. He is a director of Vitality Health, a for-profit health and wellness company.
Mr. Dolan has 25+ years of operating experience, with 18 years at Bristol-Myers Squibb and, prior to that, 8 years at General Foods. Beginning his career in marketing at General Foods, he moved to Bristol-Myers in 1988. Among other responsibilities, he was President of the company’s Products Division (1993) and Mead Johnson Nutritionals (1995). He was Group President of Medical Devices and Nutritionals (1997) and later promoted to become President of Bristol-Myers Squibb (2000) and Chairman and CEO of the company (2001). He served until 2006 as the company’s CEO. From 2008 – 2011 he was a director of Gemin X, initially on the board as an independent director and, from 2009 until the company’s sale in 2011, he was Chairman and CEO.
Mr. Dolan is a Vice Chair of the Board of Tufts University and a member of the Board of Overseers of the Tuck School at Dartmouth. He also serves as a member of the Board for the Partnership for a Healthier America, and is currently a member of the Board of Directors of the National Center on Addiction and Substance Abuse at Columbia University. He served on the boards of the American Express Company, C-Change (a cancer coalition organization), and was Chairman of the Pharmaceutical Research and Manufacturers of America.
Mr. Dolan holds a Bachelor of Arts degree from Tufts University and a Master of Business Administration degree from the Amos Tuck School of Business at Dartmouth. He has run several marathons, numerous triathlons and completed the Hawaii Ironman Triathlon in October 2007.
Last updated: February 11, 2013
